Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hagger, Corinne
Buckley, Peter
Kenny, John T.
Friedman, Lee
Ubogy, David
and
Meltzer, Herbert Y.
1993.
Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.
Biological Psychiatry,
Vol. 34,
Issue. 10,
p.
702.
Buckley, Peter F.
and
Meltzer, Herbert Y.
1993.
Clozapine and NMS.
British Journal of Psychiatry,
Vol. 162,
Issue. 4,
p.
566.
Meltzer, Herbert Y
1993.
Serotonin-Dopamine Interactions and Atypical Antipsychotic Drugs.
Psychiatric Annals,
Vol. 23,
Issue. 4,
p.
193.
Ellenbroek, B.A.
1993.
Treatment of schizophrenia: A clinical and preclinical evaluation of neuroleptic drugs.
Pharmacology & Therapeutics,
Vol. 57,
Issue. 1,
p.
1.
Howard, Harry R.
and
Seeger, Thomas F.
1993.
Vol. 28,
Issue. ,
p.
39.
MOZES, TAMAR
TOREN, PAZ
CHERNAUZAN, NADEJDA
MESTER, ROBERTO
YORAN-HEGESH, RONI
BLUMENSOHN, RACHEL
and
WEIZMAN, ABRAHAM
1994.
Clozapine Treatment in Very Early Onset Schizophrenia.
Journal of the American Academy of Child & Adolescent Psychiatry,
Vol. 33,
Issue. 1,
p.
65.
Prinssen, Eric P.M.
Ellenbroek, Bart A.
and
Cools, Alexander R.
1994.
Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine.
European Journal of Pharmacology,
Vol. 262,
Issue. 1-2,
p.
167.
Ulrich, Uwe
Nowara, Ingrid
and
Rossmanith, Winfried G.
1994.
Serotoninergic control of gonadotrophin and prolactin secretion in women.
Clinical Endocrinology,
Vol. 41,
Issue. 6,
p.
779.
Asakura, Wataru
Matsumoto, Kinzo
and
Watanabe, Hiroshi
1995.
REM sleep deprivation treatment enhances the effect of clozapine in the forced swimming test.
General Pharmacology: The Vascular System,
Vol. 26,
Issue. 6,
p.
1225.
Dubovsky, Steven L.
and
Thomas, Marshall
1995.
Beyond specificity: Effects of serotonin and serotonergic treatments on psychobiological dysfunction.
Journal of Psychosomatic Research,
Vol. 39,
Issue. 4,
p.
429.
Cools, A. R.
Prinssen, E. P. M.
and
Ellenbroek, B. A.
1995.
The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine.
Psychopharmacology,
Vol. 119,
Issue. 4,
p.
428.
Kunovac, Jelena L.
and
Stahl, Stephen M.
1995.
Biochemical pharmacology of serotonin receptor subtypes: hypotheses for clinical applications of selective serotonin ligands.
International Review of Psychiatry,
Vol. 7,
Issue. 1,
p.
55.
Tsibulsky, Vladimir
Dashevsky, Boris
and
Frank, Robert A.
1995.
D2 and 5‐HT2 modulation of psychostimulant‐induced facilitation of brain stimulation reward.
Drug Development Research,
Vol. 34,
Issue. 3,
p.
297.
Nöthen, M.M.
Rietschel, M.
Erdmann, J.
Oberländer, H.
Möller, H-J.
Naber, D.
Propping, P.
Burnet, PhilipW.J.
and
Harrison, PaulJ.
1995.
Genetic variation of the 5-HT2A receptor and response to clozapine.
The Lancet,
Vol. 346,
Issue. 8979,
p.
908.
Schmidt, Christopher J.
and
Fadayel, Gina M.
1995.
The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat.
European Journal of Pharmacology,
Vol. 273,
Issue. 3,
p.
273.
Silver, Henry
Odnopozov, Natan
Jahjah, Nabil
and
Barash, Igor
1995.
Chronic fluvoxamine treatment reduces platelet MAO activity in medicated chronic schizophrenics.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. 4,
p.
321.
Prinssen, Eric. P.M.
Ellenbroek, Bart A.
Stamatovic, Branka
and
Cools, Alexander R.
1995.
Role of striatal dopamine D2 receptors in the paw test, an animal model for the therapeutic efficacy and extrapyramidal side effects of neuroleptic drugs.
Brain Research,
Vol. 673,
Issue. 2,
p.
283.
Schmidt, Christopher J.
Sorensen, Stephen M.
Kenne, John H.
Carr, Albert A.
and
Palfreyman, Michael G.
1995.
The role of 5-HT2A receptors in antipsychotic activity.
Life Sciences,
Vol. 56,
Issue. 25,
p.
2209.
Rabey, J. M.
Treves, T. A.
Neufeld, M. Y.
Orlov, E.
and
Korczyn, A. D.
1995.
Low-dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease.
Neurology,
Vol. 45,
Issue. 3,
p.
432.
Frank, Robert A.
Tsibulsky, Vladimir
Grocki, Shannon
Dashevsky, Boris
Kehne, John H.
Schmidt, Christopher J.
and
Sorensen, Stephen M.
1995.
Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward.
Pharmacology Biochemistry and Behavior,
Vol. 52,
Issue. 4,
p.
799.
eLetters
No eLetters have been published for this article.